Healthcare executives have high expectations for the potential of big data, with a talent shortage and lack of resources being the biggest barriers to use, according to a new survey from the Society of Actuaries.
In the survey, three numbers stand out:
- 87 percent say they perceive data as impactful on future business
- 84 percent say they have had difficulty finding staff skilled in optimizing big data
- 45 percent plan to hire more skilled staff within the next year
Of the …
Health care providers are just beginning to figure out how big data can deliver better care at lower costs, according to Iya Khalil, EVP and co-founder of GNS Healthcare, and other speakers at The Economist’s Health Care Forum in Boston.
Talk of using large-scale data analysis to develop customized treatment plans is premature since most health care providers are still edging toward joining the big-data movement, said Charlie Schick, IBM’s director of big data, healthcare and life sciences, during a …
Aetna announced a new metabolic syndrome risk-reduction program, which builds off Aetna and GNS Healthcare’s successful creation of predictive models that identify at-risk individuals with a high degree of accuracy. The program, being implemented with Newtopia, aims to reduce a person’s Metabolic Syndrome risk factors, particularly abdominal size, through online food logging, activity tracking, behavior management, and one-on-one sessions with a personal coach.
Read the full release here.…
I recently had the privilege to sit down with healthcare visionary Don Berwick as part of my duties as co-chair of the Strata Rx healthcare and big data conference being held here in Boston next week.
Berwick, who founded the Institute for Healthcare Improvement and recently served as head of CMS, is best known for the idea of the “Triple Aim,” which says our society needs better care, better health, and lower cost. This goal may seem obvious, but we’re …
NEW YORK (GenomeWeb News) – The Inova Translational Medicine Institute and GNS Healthcare today announced a deal to develop and commercialize computer models based on GNS’ technology.
The models will be built using GNS’ Reverse Engineering and Forward Simulation data analysis platform, next-generation sequencing, and electronic medical record data that can predict preterm live birth risk, Inova and GNS said.
The models and corresponding software will be licensed to academic researchers, health systems, pharmaceutical firms and biotech companies. According to …
Could crunching data from genomes and electronic health records prevent some of the thousands of U.S. infant deaths from preterm births? GNS Healthcare, a Big Data analytics firm, and Inova Translational Medicine Institute (ITMI) have embarked on a new project to create computer models that predict risk of preterm birth. So maybe.
Cambridge, MA-based GNS Healthcare says that the models would be shared with academics, healthcare groups and biopharma organizations to improve diagnostics and treatments of preterm birth. This …
Though it affects one out of every nine babies born in the United States, scientists know surprisingly little about what causes preterm birth. To address the issue, two organizations are hedging their bets on big data and genomics, partnering to develop computer models that can predict the risk that a woman’s child will be born before reaching 37 weeks of gestation.
The Cambridge, Massachusetts-based big data firm GNS Healthcare is collaborating with the Inova Translational Medicine Institute (ITMI) at Inova …
Inova Health System has struck a deal with a Boston-area technology firm to develop software that could predict premature births, the most aggressive step yet toward commercialization of its genomics research.
Under the terms of the partnership, the Inova Translational Medicine Institute will allow GNS Healthcare Inc. access to its database of nearly 2,400 patients’ complete gene maps compiled by researchers since 2011, which includes about 800 families of a mother, father and a newborn baby each.
Then, together, …
Big data analytics are the future of medicine. This ability to analyze massive quantities of data is key to making personalized medicine the treatment norm. With the deep analyses developed through big data analytics, drug developers can match patients to therapies most likely to work for them, as well as identify new therapeutic approaches. Health plans can use the information to develop comparative effectiveness models for specific scenarios and develop more effective and cost-effective approaches to healthcare delivery.
GNS Healthcare’s …
A big data analytics platform from GNS and Cambia will spot causal patterns in health data to find ways to keep patients on their medication schedules.
Amid big data analytics’ increasing role in health care, software developer GNS Healthcare and nonprofit health plan provider Cambia Health Solutions announced June 27 that they will build a medication adherence platform to allow health professionals to study the causal relationship between adhering to medication routines and reducing health care costs.
Called Medication Adherence, …